Oral immunization with Salmonella typhi Ty21a-based clones expressing Vibrio cholerae O-antigen: serum bactericidal antibody responses in man in relation to pre-immunization antibody levels
- PMID: 1725837
- DOI: 10.1016/0264-410x(91)90007-s
Oral immunization with Salmonella typhi Ty21a-based clones expressing Vibrio cholerae O-antigen: serum bactericidal antibody responses in man in relation to pre-immunization antibody levels
Abstract
Previous studies have shown that oral immunization with Salmonella typhi Ty21a-based clones expressing Vibrio cholerae O-antigen elicits serum antibody responses against the foreign polysaccharide in human volunteers. These responses are conveniently assayed by complement-dependent bacteriolysis of V. cholerae. In this report the bactericidal responses generated by two such clones are analysed in relation to the pre-immunization titres of various serum antibodies. A significant association was found, in that recipients with higher prevaccine titres of anti-V. cholerae bactericidal antibodies were less likely to register significant bactericidal responses following immunization. These results are discussed in relation to the concept of vaccine exclusion.
Similar articles
-
In vivo evidence of immunological masking of the Vibrio cholerae O antigen of a hybrid Salmonella typhi Ty21a-Vibrio cholerae oral vaccine in humans.Vaccine. 1991 Jul;9(7):515-20. doi: 10.1016/0264-410x(91)90039-9. Vaccine. 1991. PMID: 1716810 Clinical Trial.
-
Characterization and immunogenicity of EX880, a Salmonella typhi Ty21a-based clone which produces Vibrio cholerae O antigen.Infect Immun. 1991 Jul;59(7):2279-84. doi: 10.1128/iai.59.7.2279-2284.1991. Infect Immun. 1991. PMID: 1711014 Free PMC article.
-
The antibody response to an oral Ty21a-based typhoid-cholera hybrid is unaffected by prior oral vaccination with Ty21a.J Infect Dis. 1992 Jan;165(1):182-3. doi: 10.1093/infdis/165.1.182. J Infect Dis. 1992. PMID: 1727891 Clinical Trial. No abstract available.
-
A review of the current status of enteric vaccines.P N G Med J. 1995 Dec;38(4):325-31. P N G Med J. 1995. PMID: 9522876 Review.
-
Experience with registered mucosal vaccines.Vaccine. 2003 Jan 30;21(7-8):678-83. doi: 10.1016/s0264-410x(02)00579-0. Vaccine. 2003. PMID: 12531339 Review.
Cited by
-
Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate.Infect Immun. 1997 May;65(5):1579-83. doi: 10.1128/iai.65.5.1579-1583.1997. Infect Immun. 1997. PMID: 9125533 Free PMC article.
-
Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139.Clin Diagn Lab Immunol. 2002 Mar;9(2):383-7. doi: 10.1128/cdli.9.2.383-387.2002. Clin Diagn Lab Immunol. 2002. PMID: 11874883 Free PMC article.
-
Enteric pathogens as vaccine vectors for foreign antigen delivery.Infect Immun. 2004 Oct;72(10):5535-47. doi: 10.1128/IAI.72.10.5535-5547.2004. Infect Immun. 2004. PMID: 15385450 Free PMC article. Review. No abstract available.
-
Clearance of Pseudomonas aeruginosa from the murine gastrointestinal tract is effectively mediated by O-antigen-specific circulating antibodies.Infect Immun. 1995 Aug;63(8):2818-25. doi: 10.1128/iai.63.8.2818-2825.1995. Infect Immun. 1995. PMID: 7542632 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources